![Barry D. Garfinkle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barry D. Garfinkle
Directeur/Membre du Conseil chez Arrevus, Inc.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Robert J. Schotzinger | M | 63 |
Arrevus, Inc.
![]() Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | 5 ans |
Joseph T. McMahon | M | - |
Arrevus, Inc.
![]() Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | - |
Robert V. House | M | - |
Arrevus, Inc.
![]() Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | - |
Joseph W. St. Geme | M | - |
Arrevus, Inc.
![]() Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 4 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Barry D. Garfinkle
- Réseau Personnel